Edesa Biotech Net debt/EBITDA
Qual é o Net debt/EBITDA de Edesa Biotech?
O Net debt/EBITDA de Edesa Biotech, Inc. é 0.68
Qual é a definição de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA de empresas na Setor Health Care em NASDAQ em comparação com Edesa Biotech
O que Edesa Biotech faz?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Empresas com net debt/ebitda semelhantes a Edesa Biotech
- Robex Resources tem Net debt/EBITDA de 0.67
- Livehire tem Net debt/EBITDA de 0.67
- cmlog tem Net debt/EBITDA de 0.67
- CF Industries tem Net debt/EBITDA de 0.68
- FTI Consulting tem Net debt/EBITDA de 0.68
- Optibiotix Health Plc tem Net debt/EBITDA de 0.68
- Edesa Biotech tem Net debt/EBITDA de 0.68
- TransAtlantic Petroleum tem Net debt/EBITDA de 0.68
- Verrica Pharmaceuticals Inc tem Net debt/EBITDA de 0.68
- Globus Medical Inc tem Net debt/EBITDA de 0.68
- EBay tem Net debt/EBITDA de 0.68
- Focusrite Plc tem Net debt/EBITDA de 0.68
- Grid Metals tem Net debt/EBITDA de 0.69